WELL Health Technologies Corp. (TSE:WELL) Receives Consensus Rating of “Moderate Buy” from Analysts

WELL Health Technologies Corp. (TSE:WELL) has earned a consensus rating of “Moderate Buy” from the six analysts that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is C$7.13.

Separately, Stifel Nicolaus reduced their target price on WELL Health Technologies from C$11.00 to C$10.00 in a report on Monday, April 29th.

WELL Health Technologies Price Performance

TSE:WELL opened at C$4.60 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.48 and a debt-to-equity ratio of 48.62. The firm has a market cap of C$1.13 billion, a PE ratio of 38.33, a price-to-earnings-growth ratio of -1.93 and a beta of 1.24. WELL Health Technologies has a 12 month low of C$3.41 and a 12 month high of C$4.93. The company’s 50-day moving average price is C$3.96 and its two-hundred day moving average price is C$3.87.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.